Arginine-enriched diets: Rationale for use and experimental data;Regimes enrichis en arginine: Bases conceptuelles et donnees experimentales

Nutrition Clinique et Metabolisme

Volumn 10, Issue 2, 1996, Pages 89-95

  Cynober, Luc ^a,b,c   Vasson, Marie Paule ^a   Aussel, Christian ^b  

^a CRNH AUVERGNE   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Arginine; cancer; experimental models; immunity; trauma

Indexed keywords

ARGININE; GROWTH HORMONE; INSULIN; LIVER PROTEIN; NITRIC OXIDE; ORNITHINE; POLYAMINE;

ARTICLE; CANCER INHIBITION; CELLULAR IMMUNITY; DIET; ENTERIC FEEDING; GROWTH HORMONE RELEASE; HOST RESISTANCE; HUMAN; INSULIN RELEASE; NITROGEN BALANCE; NONHUMAN; PARENTERAL NUTRITION; PROTEIN SYNTHESIS; SEPSIS; WOUND HEALING;

EID: 0030056709     PISSN: 09850562     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0985-0562(96)80032-X     Document Type: Article

References (52)

1. Rogers QR, Visek WJ. Metabolic role of urea cycle intermediates: nutritional and clinical aspects. J Nutr 1985 ; 115 : 505-541.
2. Young VR, El-Khoury AE. The notion of the nutritional essentiality of amino acids revisited, with a note on the indispensable amino acid requirements in adults. In: Cynober L Ed. Amino acid metabolism and therapy in health and nutritional disease. Boca Raton : CRC Press. 1995 ; 191-232.
3. Czarnecki GL, Baker DH. Urea cycle function in the dog with emphasis on the role of arginine. J Nutr 1984 ; 114 : 581-90.
4. Morris JG. Nutritional and metabolic responses to arginine deficiency in carnivores. J Nutr 1985 ; 115 : 524-31.
5. Barbul A. Arginine: biochemistry, physiology and therapeutic implications. JPEN 1986 ; 10 : 227-38.
6. Hoogenraad N, Totino N, Elmer H, Wraight C, Alewood P, Johns RB. Inhibition of intestinal citrulline synthesis causes severe growth retardation in rats. Am J Physiol 1985 ; 249 : G792-9.
7. Kirk SJ, Barbul A. Role of arginine in trauma, sepsis and immunity. JPEN 1990 ; 14 (suppl) : 226-91.
8. Seifter E, Rettura G, Barbul A, Levenson SM. Arginine: an essential amino acid for injured rats. Surgery 1978 ; 84 : 224-30.
9. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993 ; 329 : 2002-12.
10. Cynober L, Le Boucher J, Vasson MP. Arginine metabolism in mammals. J Nutr Biochem 1995 ; 6 : 403-12.
11. White MF, Christensen HN. Cationic amino acid transport into cultured animal cells. II. Transport system barely perceptible in ordinary hepatocytes, but active in hepatoma cell lines. J Biol Chem 1982 ; 257 : 4450-7.
12. Cynober L. The role or arginine and related compounds in intestinal functions. In: Kinney J.M., Tucker H.N. Organ metabolism and nutrition : ideas for future critical care. New York : Raven Press 1994 ; 245-55.
13. Barbul A. The use of arginine in clinical practice. In: Cynober L Ed. Amino acid metabolism and therapy in health and nutritional disease. Boca Raton : CRC Press : 1995 ; 361-73.
14. Muruganandam A, Mutus B. Isolation of nitric oxide synthase from human platelets. Biochim Biophys Acta 1994 ; 1200 : 1-6.
15. Anggard E. Nitric oxide : mediator, murderer and medicine. Lancet 1994 ; 343 : 1199-206.
16. Morris SM, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994 ; 266 : E829-39.
17. Albina JE, Abate JA, Henry Jr WL. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen stimulated T-cell proliferation. J Immunol 1991 ; 147 : 144-48.
18. Gonce SJ, Peck MD, Alexander W, Miskell PW. Arginine supplementation and its effect on established peritonitis in guinea pigs. JPEN 1990 ; 14 : 237-44.
19. Barbul A, Wasserkrug HL, Yoshimura N, Tao R, Efron G. High arginine levels in intravenous hyperalimentation abrogate post-traumatic immune suppression. J Surg Res 1984 ; 36 : 620-4.
20. Barbul A, Sisto DA, Wasserkrug HL, Yoshimura NN, Efron G. Metabolic and immune effects of arginine in postinjury hyperalimentation. J Trauma 1981 ; 21 : 970-4.
21. Leon P, Redmond P, Stein TP, Shou J, Schulter MD, Kelly C et al. Arginine supplementation improves histone and acute-phase protein synthesis during Gram-negative sepsis in the rat. JPEN 1991 ; 15 : 503-8.
22. Barbul A, Wasserkrug HL, Penberthy LT, Yoshimura NN, Tao RC, Efron G. Optimal levels of arginine in maintainance intravenous hyperalimentation. JPEN 1984 ; 8 : 281-4.
23. Elsair J, Khelfat K, Aoul M, Iklef F. Effets de l'aspartate d'arginine, administré par voie orale, sur le bilan d'azote du lapin normal ou traité par l'hydrocortisone. Path Biol 1982 ; 30 : 206-10.
24. Mulloy AL, Kari FW, Visek WJ. Dietary arginine, insulin secretion, glucose tolerance and liver lipids during repletion of protein-depleted rats. Horm Metab Res 1982 ; 14 : 471-5.
25. Nu Y, Moriguchi S, Kishino Y. Enhanced phagocytosis of rat alveolar macrophages by intravenous infusion of an arginine-enriched solution. J Nutr Sci Vitaminol 1992 ; 38 : 565-78.
26. Torre PM, Ronnenberg GR, Hartman WJ, Prior RL. Oral arginine supplementation does not affect lymphocyte proliferation during endotoxin-induced inflammation in rats. J Nutr 1993 ; 123 : 481-8.
27. Adjei AA, Yamauchi K, Nakasone Y, Konishi M, Yamamoto S. Arginine-supplemented diets inhibit endotoxin-induced bacterial translocation in mice. Nutrition 1995 ; 11 : 371-4.
28. Ronnenberg AG, Gross KL, Hartman WJ, Meydani SN, Prior RL. Dietary arginine supplementation does not enhance lymphocyte proliferation or interleukin-2 production in young and aged rats. J Nutr 1991 ; 121 : 1270-8.
29. Fabris N, Mocchegiani E, Muzzioli M. Recovery of age-related decline of thymic endocrine activity and PHA response by lysin-arginine combination. Int J Immunopharmacol 1986 ; 8 : 677-85.
30. Chandra RK, Baker M, Whang S, All B. Effect of two feeding formulas on immune responses and mortality in mice challenged with Listeria monocytogenes. Immunol lett 1991 ; 27 : 45-8.
31. Zapata-Sirvent RL, Hansbrough JF. Effect of indomethacin and Impact liquid diet administration of inflammatory mediator production by murine splenocytes after burn injury. J Burn Care Rehabil 1992 ; 13 : 538-45.
32. Saito H, Trocki O, Wang SL, Gonce SJ, Joffe SN, Alexander JW. Metabolic and immune effects of dietary arginine supplementation after burn. Arch Surg 1987 ; 122 : 784-9.
33. Kennedy JA, Kirk SJ, Mc Crory DC, Halliday MI, Barclay GR, Rowlands BJ. Modulation of immune function and weight loss by L-arginine in obstructive jaundice in the rat. Brit J Surg 1994 ; 81 : 1199-201.
34. Kirk SJ, Regan MC, Wasserkrug HL, Sodeyama M, Barbul A. Arginine enhances T-cell responses in athymic nude mice. JPEN, 1992 ; 16 : 429-32.
35. Barbul A, Rettura G, Levenson SM, Seifter E. Wound healing and thymotropic effects or arginine : pituitary mechanism of action. Am J Clin Nutr 1983 ; 37 : 786-95.
36. Chyun JH, Griminger P. Improvement of nitrogen retention by arginine and glycine supplementation and relation to collagen synthesis in traumatized mature and aged rats. J Nutr 1984 ; 114 : 1697-704.
37. Adams E. Metabolism of proline and of hydroxyproline. Int Rev Connective Tissue Res 1970 ; 5 : 1-91.
38. Tachibana K, Mukai K, Hiraoka I, Moriguchi S, Takama S, Kisnino Y. Evaluation of the effect of arginine-enriched amino acid solution on tumor growth. JPEN, 1985 ; 9 : 428-34.
39. Cynober L. Métabolisme des acides aminés chez le cancéreux. Influence du traitement. Nutr Clin Métabol 1987 ; 1 : 100-7.
40. Ye SL, Istfan NW, Driscoll DF, Bistrian BR. Tumor and host-response to arginine and branched chain amino acid-enriched total parenteral nutrition. Cancer 1992 ; 69 : 261-70.
41. Reynolds JV, Daly JM, Shou J, Sigal R, Ziegler MM, Naji A. Immunologic effects of arginine supplementation in tumor-bearing and non-tumor bearing hosts. Ann Surg 1990 ; 211 : 202-10.
42. Reynolds JV, Thom AKT, Zhang SM, Ziegler MM, Naji A, Daly JM. Arginine, protein malnutrition and cancer. J Surg Res 1988 ; 45 : 513-22.
43. Oka T, Ohwada K, Nagao M, Kitazato K. Effect of arginine-enriched total parenteral nutrition on the host-tumor interaction on cancer-bearing rats ; JPEN 1993 ; 17 : 375-83.
44. Oka T, Ohwada K, Nagao M, Kitazato K, Kishino Y. Arginine-enriched solution induces a marked increase in muscle glutamine concentration and enhances muscle protein synthesis in tumor-bearing rats. JPEN 1994 ; 18 : 491-6.
45. Gonzales GG, Byus CV. Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two-stage epidermial carcinogenesis in the mouse. Cancer Res 1991 ; 51 : 2932-9.
46. Rettura G., Barbul A., Levenson SM, Seifter E. Citrulline does not share the thymotropic properties of arginine and ornithine. Fed Proc 1979 ; 38 : 289 (résumé).
47. Cynober L, Vasson MP, Farges MC, Le Boucher J, Giboudeau J. Acides aminés et immunité. Nutr Clin Métabol 1993 ; 7 : 183-9.
48. Rennie MJ, Babij P, Taylor PM, Hundal HS, Mc Lennan P, Watt PW et al. Characteristics of a glutamine carier in skeletal muscle have important consequences for nitrogen loss in injury, infection and chronic disease. Lancet 1986 ; ii : 1008-12.
49. Kelly E, Morris SM, Billiar TR. Nitric oxide, sepsis and arginine metabolism. JPEN 1995 ; 19 : 234-8.
50. Adjei AA, Matsumoto Y, Oky T, Hiroi Y, Yamamoto S. Dietary arginine and glutamine combination improves survival in septic mice. Nutr Res 1991 ; 14 : 1591-9.
51. Chandra RK, Wang S, Au B. Enriched feeding formula and immune responses and outcome after Listeria monocytogenes challenge in mice. Nutrition 1992 ; 8 : 426-9.
52. Madden HP, Breslin RJ, Wasserkrug HL, Efron G, Barbul A. Stimulation of T-cell immunity by arginine enhances survival in peritonitis. J Surg Res 1988 ; 44 : 658-63.